This page is part of the FHIR Specification (v1.1.0: STU 3 Ballot 1). The current version which supercedes this version is 5.0.0. For a full list of available versions, see the Directory of published versions . Page versions: R5 R4B R4 R3 R2
This is a frozen snapshot of the FHIR specification created for the purpose of balloting the GAO implementation Guide. It includes draft changes that may be part of the future DSTU 2.1 release but further change is expected. Readers should focus solely on the GAO implementation content, and FHIR DSTU 2 for other purposes.
Drug-drug interaction between prescription and medication statement (id = "ddi")
<DetectedIssue xmlns="http://hl7.org/fhir"> <id value="ddi"/> <text> <status value="generated"/> <div xmlns="http://www.w3.org/1999/xhtml"> <p><b>Severity: High</b> - Risk of internal bleeding</p> <p>Those who take acetaminophen along with the widely used blood-thinning drug warfarin may face the risk of serious internal bleeding. People on warfarin who take acetaminophen for at least seven days in a row should be closely watched for bleeding.</p> <ul> <li><a href="MedicationStatement/tylenol">500 mg Acetaminophen tablet 1/day, PRN since 2010</a></li> <li><a href="MedicationOrder/warfarin">Warfarin 1 MG TAB prescribed Jan. 5, 2014</a></li> </ul> <p>Mitigation: Jan 5, 2014 by Dr. Adam Careful: </p> <p>Asked patient to discontinue regular use of Tylenol and to consult with clinician if they need to resume to allow appropriate INR monitoring</p> </div> </text> <category> <coding> <system value="http://hl7.org/fhir/v3/ActCode"/> <code value="DRG"/> <display value="Drug Interaction Alert"/> </coding> </category> <severity value="high"/> <implicated> <reference value="MedicationStatement/tylenol"/> <display value="500 mg Acetaminophen tablet 1/day, PRN since 2010"/> </implicated> <implicated> <reference value="MedicationOrder/warfarin"/> <display value="Warfarin 1 MG TAB prescribed Jan. 5, 2014"/> </implicated> <detail value="Risk of internal bleeding. Those who take acetaminophen along with the widely used blood-thinning drug warfarin may face the risk of serious internal bleeding. People on warfarin who take acetaminophen for at least seven days in a row should be closely watched for bleeding."/> <date value="2014-01-05"/> <author> <reference value="Device/dsp"/> </author> <mitigation> <action> <coding> <system value="http://hl7.org/fhir/v3/ActCode"/> <code value="13"/> <display value="Stopped Concurrent Therapy"/> </coding> <text value="Asked patient to discontinue regular use of Tylenol and to consult with clinician if they need to resume to allow appropriate INR monitoring"/> </action> <date value="2014-01-05"/> <author> <reference value="Practitioner/example"/> <display value="Dr. Adam Careful"/> </author> </mitigation> </DetectedIssue>
Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.